News | Radiation Therapy | January 03, 2018

Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases

Results indicate the brain receives less dose with radiosurgery, even when treating 10 or more lesions

Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases

January 3, 2018 — Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem. Radiation is often used to treat deposits in the brain, but the best technique to deliver radiation can be controversial. Whole-brain radiation therapy, as its name suggest, treats the entire brain but can be associated with notable cognitive side effects. Another strategy, radiosurgery, directs highly-focused radiation only to the sites of metastasis, largely sparing the normal brain.

The challenge has been to define in which circumstances each technique is best. The debate has centered on the number of brain metastases, with the field generally agreeing that with three or fewer deposits, radiosurgery is the preferred approach, and then switching to the use of whole-brain radiation to treat four or more deposits.

A University of Colorado Cancer Center study published in the Journal of Thoracic Oncology explores the use of radiosurgery in advanced lung cancer patients with four or more brain lesions – in some cases, dramatically more than four lesions – and shows that in a subset of patients, radiosurgery may be the best choice even when the number of brain lesions far exceeds the established three-lesion threshold.

In addition to discovering if radiosurgery could be effective in patients with greater than four brain lesions, the clinical study hoped to answer two more important questions — namely, if you use radiosurgery to treat only the known sites of disease, might you be missing smaller deposits that would have been treated as a byproduct of whole-brain radiation, leading to worse long-term outcomes? And if you treat multiple sites with radiosurgery, at some point does the radiation dose to the normal parts of the brain become equivalent to that from whole-brain radiotherapy?

“It used to be that once lung cancer metastasized to the brain, the prognosis was poor. Whole-brain radiation therapy decreases the risk of death from neurologic causes, but at a steep cost. This study suggests that for lung cancer patients on targeted therapies whose cancer has spread to the brain, the use of radiosurgery makes it rare to die of causes related to brain metastases,” said Tyler Robin, M.D., Ph.D., senior resident in radiation oncology at the CU School of Medicine and the paper’s first author. Robin collaborated with senior author, Chad G. Rusthoven, M.D., assistant professor in radiation oncology at the University of Colorado Cancer Center.

“Despite the fact that patients on this study had multiple brain metastases, the outcomes were excellent with radiosurgery alone, with overall survival measured on the order of years,” said Rusthoven.

The study also asked whether radiosurgery to multiple lesions is likely to subject patients to the same cognitive risks as whole-brain radiation therapy – in other words, if you are using radiosurgery to treat 5, 10, 15 or 20 brain lesions, at some point are you effectively irradiating the whole brain?

“Even when we treated over 10 brain metastases in one session, the dose to the whole brain was phenomenally lower than with whole-brain radiotherapy,” Robin said.

The group measured radiation dose in two ways – to the whole brain and also specifically to the hippocampus, the brain structure responsible for processing new memories, which has been blamed for the cognitive side effects associated with brain radiation.

Whole-brain radiation delivers a radiation dose of approximately 30 Gy to the entire brain. A technique known as “hippocampal-sparing” or “hippocampal-avoidance” radiation delivers the same dose of radiation to the bulk of the brain, but only about 10 Gy to the hippocampus. The maximum radiation dose experienced with radiosurgery, even with many metastases, was 1.2 Gy in the hippocampus and 0.8 Gy across the whole brain.

“The very low doses of radiation to the normal brain observed with radiosurgery compared to whole-brain radiation has the potential to dramatically alter the risk of cognitive side effects,” said Rusthoven. “As the field of oncology evolves, we have to evolve with it. Patients with cancer who are eligible for targeted therapies are living longer than ever before, making treatment strategies that support long term quality of life even more important.”

For more information: www.jto.org

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Check-Cap Announces Interim Results of European Study of C-Scan System Version 3
News | Colonoscopy Systems | September 04, 2018
Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...